174 related articles for article (PubMed ID: 11152530)
1. Role of bcl-2 in Epstein-Barr virus-induced malignant conversion of Burkitt's lymphoma cell line Akata.
Komano J; Takada K
J Virol; 2001 Feb; 75(3):1561-4. PubMed ID: 11152530
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction.
Kitagawa N; Goto M; Kurozumi K; Maruo S; Fukayama M; Naoe T; Yasukawa M; Hino K; Suzuki T; Todo S; Takada K
EMBO J; 2000 Dec; 19(24):6742-50. PubMed ID: 11118209
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
[TBL] [Abstract][Full Text] [Related]
4. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
[TBL] [Abstract][Full Text] [Related]
5. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines.
Röth A; Pfaff P; Lange W; Finke J
Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata.
Komano J; Maruo S; Kurozumi K; Oda T; Takada K
J Virol; 1999 Dec; 73(12):9827-31. PubMed ID: 10559294
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata.
Komano J; Sugiura M; Takada K
J Virol; 1998 Nov; 72(11):9150-6. PubMed ID: 9765461
[TBL] [Abstract][Full Text] [Related]
8. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
[TBL] [Abstract][Full Text] [Related]
9. The role of Epstein-Barr virus-encoded small RNAs (EBERs) in oncogenesis.
Nanbo A; Takada K
Rev Med Virol; 2002; 12(5):321-6. PubMed ID: 12211044
[TBL] [Abstract][Full Text] [Related]
10. Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis.
Gutiérrez MI; Cherney B; Hussain A; Mostowski H; Tosato G; Magrath I; Bhatia K
Cancer Res; 1999 Feb; 59(3):696-703. PubMed ID: 9973220
[TBL] [Abstract][Full Text] [Related]
11. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line.
Wang Y; Szekely L; Okan I; Klein G; Wiman KG
Oncogene; 1993 Dec; 8(12):3427-31. PubMed ID: 8247547
[TBL] [Abstract][Full Text] [Related]
12. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
13. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
[TBL] [Abstract][Full Text] [Related]
14. Modulation of innate immunity system by Epstein-Barr virus-encoded non-coding RNA and oncogenesis.
Samanta M; Takada K
Cancer Sci; 2010 Jan; 101(1):29-35. PubMed ID: 19886912
[TBL] [Abstract][Full Text] [Related]
15. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
[TBL] [Abstract][Full Text] [Related]
16. The role of EBERs in oncogenesis.
Takada K; Nanbo A
Semin Cancer Biol; 2001 Dec; 11(6):461-7. PubMed ID: 11669608
[TBL] [Abstract][Full Text] [Related]
17. Role of Epstein-Barr virus in Burkitt's lymphoma.
Takada K
Curr Top Microbiol Immunol; 2001; 258():141-51. PubMed ID: 11443859
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 antisense oligodeoxynucleotide therapy of Epstein-Barr virus-associated lymphoproliferative disease in severe combined immunodeficient mice.
Guinness ME; Kenney JL; Reiss M; Lacy J
Cancer Res; 2000 Oct; 60(19):5354-8. PubMed ID: 11034070
[TBL] [Abstract][Full Text] [Related]
19. Involvement of caspase activation and mitochondrial stress in trichostatin A-induced apoptosis of Burkitt's lymphoma cell line, Akata.
Son YO; Choi KC; Lee JC; Kook SH; Lee HJ; Jeon YM; Kim JG; Kim J; Lee WK; Jang YS
J Cell Biochem; 2006 Dec; 99(5):1420-30. PubMed ID: 16817225
[TBL] [Abstract][Full Text] [Related]
20. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]